1861.9000 -2.50 (-0.13%)
NSE Oct 17, 2025 15:31 PM
Volume: 247.4K
 

1861.90
-0.13%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues grew 8% YoY to | 2457 crore (I-direct estimate: | 3043 crore) mainly due to 53.5% YoY growth in the US to | 1000 crore (Idirect estimate: | 1534 crore) led by gZetia Exclusivity. Miss vis--vis I-direct estimate was due to lower US traction, way below estimates EBITDA margins increased 481 bps YoY to 18.1% (I-direct estimate: 35.2%). The YoY increase is mainly attributable to lower base margins in Q4FY16. EBITDA increased 46% YoY to | 444 crore Adjusted net profit increased 23.5% YoY to | 184 crore but came in...
Glenmark Pharmaceuticals Ltd. is trading below its 30 day SMA of 2003.0
More from Glenmark Pharmaceuticals Ltd.
Recommended